Overview

This trial is active, not recruiting.

Condition heart failure
Sponsor National Taiwan University Hospital
Start date April 2015
End date April 2017
Trial size 18 participants
Trial identifier NCT02437331, 201503067RIND

Summary

The purpose of this study is to explore the experience in being with advanced Heart failure patients.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective
Arm
the patients was diagnostic on Chronic heart failure with NYHA class 3 and 4, AHA stage D, or LVEF<40%.

Primary Outcomes

Measure
A qualitative research to decribe the experience with advanced Heart failure patients
time frame: participants will be followed for the duration of hospital stay, an expected average of 6 weeks.

Eligibility Criteria

Male or female participants at least 20 years old.

Inclusion criteria: - the patients' conscious must be clear, - vital sign is stable, - and can communicate in Mandarin Chinese or Taiwanese. exclusion criteria: - consciousness is unclear - and can't have effective communication to interviewer. - the patient reject to join this study.

Additional Information

Official title National Taipei University of Nursing and Health Science
Principal investigator keidei kao, master
Description The aim is to explore the experience of advanced Heart failure patients during the disease trajectory in Taiwan.
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by National Taiwan University Hospital.